SS
Santhanam Subramanian
About Santhanam Subramanian
Data last updated:
Santhanam Subramanian is a Cfo at Aurobindo Pharma Ltd (since 2014), Director at Apitoria Pharma Private Limited (since 2023) and Director at Eugia Pharma Specialities Limited (since 2021), and holds 8 more current directorships. The companies operate in Pharma, Chemicals and Materials and Healthcare. The 9 current companies with reported revenue have a combined latest revenue of ₹45,828 Cr; the largest is Aurobindo Pharma Ltd at ₹34,145 Cr (FY 2026). Earlier, Santhanam Subramanian was a Company Secretary at Gocl Corporation Limited (2007–2011) and Director at Engenra Biologics Private Limited (2026) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Cfo | 01 Jul 2014 | 1986 | ₹34,145 Cr (FY 2026) | Active | |
| Director | 09 Feb 2023 | 2017 | ₹6,812 Cr (FY 2025) | Active | |
| Director | 01 Oct 2021 | 2013 | ₹4,829 Cr (FY 2025) | Active | |
| Director | 01 Jul 2023 | 2020 | ₹37.55 Cr (FY 2025) | Active | |
| Director | 09 Feb 2023 | 2020 | ₹4.37 Cr (FY 2025) | Active | |
| Director | 29 Jul 2026 | 2021 | ₹7.6 Lakh (FY 2025) | Active | |
| Director | 16 Nov 2020 | 2020 | ₹2 Lakh (FY 2023) | Active | |
| Director | 16 Nov 2020 | 2020 | ₹50,000 (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Company Secretary | 25 May 2007 | 1961 | ₹949 Cr (FY 2024) | Active | |
| Director | 24 Feb 2026 | 2026 | Active | ||
| Additional Director | 26 Aug 2016 | 2008 | ₹8.9 Lakh (FY 2025) | Active | |
| Director | 20 Feb 2021 | 2021 | ₹383 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Santhanam Subramanian
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Santhanam Subramanian
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Santhanam Subramanian
Santhanam Subramanian currently holds 11 directorships: Aurobindo Pharma Ltd (Cfo, since 01 Jul 2014, revenue ₹34,145 Cr (FY 2026)); Apitoria Pharma Private Limited (Director, since 09 Feb 2023, revenue ₹6,812 Cr (FY 2025)); Eugia Pharma Specialities Limited (Director, since 01 Oct 2021, revenue ₹4,829 Cr (FY 2025)); Auroactive Pharma Private Limited (Director, since 01 Jul 2023, revenue ₹37.55 Cr (FY 2025)); Eugia Steriles Private Limited (Director, since 09 Feb 2023, revenue ₹4.37 Cr (FY 2025)); and 6 more.
Santhanam Subramanian was first appointed on 25 May 2007 as Company Secretary at Gocl Corporation Limited. The most recent appointment on record is 31 Aug 2026 at Avogent Lifesciences Private Limited.
The 9 current companies of Santhanam Subramanian that report revenue have a combined latest revenue of ₹45,828 Cr: Aurobindo Pharma Ltd ₹34,145 Cr (FY 2026); Apitoria Pharma Private Limited ₹6,812 Cr (FY 2025); Eugia Pharma Specialities Limited ₹4,829 Cr (FY 2025); Auroactive Pharma Private Limited ₹37.55 Cr (FY 2025); Eugia Steriles Private Limited ₹4.37 Cr (FY 2025); and 4 more.
Santhanam Subramanian held 4 earlier board appointments: Gocl Corporation Limited (Company Secretary, 25 May 2007 to 01 Oct 2011); Engenra Biologics Private Limited (Director, 24 Feb 2026 to 24 Jul 2026); Tergene Biotech Limited (Additional Director, 26 Aug 2016 to 28 Aug 2017); Eugia Sez Private Limited (Director, 20 Feb 2021 to 10 Aug 2026).
The current boards of Santhanam Subramanian's companies include Adi Reddy Baddigam (Aurobindo Pharma Ltd), Girish Paman Vanvari (Aurobindo Pharma Ltd), Madan Mohan Reddy Mettu (Aurobindo Pharma Ltd), Mangalam Ramasubramanian Kumar (Aurobindo Pharma Ltd), Nityananda Reddy Kambam (Aurobindo Pharma Ltd), Punita Kumar Sinha (Aurobindo Pharma Ltd), among others.